These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31837737)
1. Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors. Gagliardi C; Khalil M; Foster AE Cytotherapy; 2019 Dec; 21(12):1246-1257. PubMed ID: 31837737 [TBL] [Abstract][Full Text] [Related]
2. CAR-T cell expansion platforms yield distinct T cell differentiation states. Song HW; Prochazkova M; Shao L; Traynor R; Underwood S; Black M; Fellowes V; Shi R; Pouzolles M; Chou HC; Cheuk AT; Taylor N; Jin P; Somerville RP; Stroncek DF; Khan J; Highfill SL Cytotherapy; 2024 Jul; 26(7):757-768. PubMed ID: 38625071 [TBL] [Abstract][Full Text] [Related]
3. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314 [TBL] [Abstract][Full Text] [Related]
4. Simplified process for the production of anti-CD19-CAR-engineered T cells. Tumaini B; Lee DW; Lin T; Castiello L; Stroncek DF; Mackall C; Wayne A; Sabatino M Cytotherapy; 2013 Nov; 15(11):1406-15. PubMed ID: 23992830 [TBL] [Abstract][Full Text] [Related]
5. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells. Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645 [TBL] [Abstract][Full Text] [Related]
6. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2. Gargett T; Brown MP Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334 [TBL] [Abstract][Full Text] [Related]
7. Methods and Process Optimization for Large-Scale CAR T Expansion Using the G-Rex Cell Culture Platform. Ludwig J; Hirschel M Methods Mol Biol; 2020; 2086():165-177. PubMed ID: 31707675 [TBL] [Abstract][Full Text] [Related]
8. A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors. Hood T; Slingsby F; Sandner V; Geis W; Schmidberger T; Bevan N; Vicard Q; Hengst J; Springuel P; Dianat N; Rafiq QA Front Immunol; 2024; 15():1335932. PubMed ID: 38655265 [No Abstract] [Full Text] [Related]
9. Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture. Foster AE; Forrester K; Gottlieb DJ; Barton GW; Romagnoli JA; Bradstock KF Biotechnol Bioeng; 2004 Jan; 85(2):138-46. PubMed ID: 14704996 [TBL] [Abstract][Full Text] [Related]
10. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield. Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773 [TBL] [Abstract][Full Text] [Related]
11. Optimization of lentiviral vector transduction into peripheral blood mononuclear cells in combination with the fibronectin fragment CH-296 stimulation. Chono H; Goto Y; Yamakawa S; Tanaka S; Tosaka Y; Nukaya I; Mineno J J Biochem; 2011 Mar; 149(3):285-92. PubMed ID: 21106541 [TBL] [Abstract][Full Text] [Related]
12. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462 [TBL] [Abstract][Full Text] [Related]
13. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21. Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789 [TBL] [Abstract][Full Text] [Related]
14. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells. Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809 [TBL] [Abstract][Full Text] [Related]
15. Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center. Zhu F; Shah N; Xu H; Schneider D; Orentas R; Dropulic B; Hari P; Keever-Taylor CA Cytotherapy; 2018 Mar; 20(3):394-406. PubMed ID: 29287970 [TBL] [Abstract][Full Text] [Related]
17. A closed-culture system using a GMP-grade culture bag and anti-CD3/28 coated bead stimulation for CD4 Thitilertdecha P; Suwannachod P; Poungpairoj P; Tantithavorn V; Khowawisetsut L; Ammaranond P; Onlamoon N J Immunol Methods; 2018 Sep; 460():17-25. PubMed ID: 29894747 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells. van Schalkwyk MCI; van der Stegen SJC; Bosshard-Carter L; Graves H; Papa S; Parente-Pereira AC; Farzaneh F; Fisher CD; Hope A; Adami A; Maher J Cells; 2021 Jul; 10(7):. PubMed ID: 34359966 [TBL] [Abstract][Full Text] [Related]
19. Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy. Klapper JA; Thomasian AA; Smith DM; Gorgas GC; Wunderlich JR; Smith FO; Hampson BS; Rosenberg SA; Dudley ME J Immunol Methods; 2009 Jun; 345(1-2):90-9. PubMed ID: 19389403 [TBL] [Abstract][Full Text] [Related]
20. Closed loop bioreactor system for the ex vivo expansion of human T cells. Li M; Chin LY; Shukor S; Tamayo A; Maus MV; Parekkadan B Cytotherapy; 2019 Jan; 21(1):76-82. PubMed ID: 30497956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]